Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna Eriksson

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Cancer Research|August 30, 2018
Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant MelanomaKim Thrane, Hanna Eriksson, Jonas Maaskola, et al.
Journal of the American Academy of Dermatology|January 13, 2024
Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort studySofi Vikström, Elisavet Syriopoulou, Therese M-L Andersson, et al.
Acta Dermato-Venereologica|April 20, 2026
Sex Differences in Loss in Life Expectancy in Primary Cutaneous Melanoma, a Swedish Cohort StudyAnna Oksanen, Elisavet Syriopoulou, Kari Nielsen, et al.
European Journal of Neurology|January 24, 2023
Risk of poststroke epilepsy after reperfusion therapies: A national cohort studyHanna Eriksson, Annika Nordanstig, Alexandros Rentzos, et al.
Food Chemistry|August 2, 2024
Minimizing anti-nutritional factors in wet protein extraction from Swedish faba beans through the application of response surface methodologyJing Lu, Galia Zamaratskaia, Maud Langton, et al.
JAMA Dermatology|January 15, 2015
BRAFV600E protein expression in primary cutaneous malignant melanomas and paired metastasesHanna Eriksson, Abdlsattar Zebary, Ismini Vassilaki, et al.
Journal for Immunotherapy of Cancer|May 28, 2020
In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanomaHaris Babačić, Janne Lehtiö, Yago Pico de Coaña, et al.
Seizure|August 29, 2021
Brain injury markers in new-onset seizures in adults: A pilot studyHanna Eriksson, Rakesh Kumar Banote, David Larsson, et al.
Behavioural and Cognitive Psychotherapy|July 9, 2021
Treating co-morbid insomnia and social anxiety disorder with sequential CBT protocols: a single-case experimental studyDaniel Wallsten, Annika Norell-Clarke, Sven Alfonsson, et al.
Journal of the American Academy of Dermatology|May 6, 2014
Risk of cutaneous malignant melanoma in patients with celiac disease: a population-based studyBenjamin Lebwohl, Hanna Eriksson, Johan Hansson, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Cancer Research|August 30, 2018
Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant MelanomaKim Thrane, Hanna Eriksson, Jonas Maaskola, et al.
Journal of the American Academy of Dermatology|January 13, 2024
Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort studySofi Vikström, Elisavet Syriopoulou, Therese M-L Andersson, et al.
Acta Dermato-Venereologica|April 20, 2026
Sex Differences in Loss in Life Expectancy in Primary Cutaneous Melanoma, a Swedish Cohort StudyAnna Oksanen, Elisavet Syriopoulou, Kari Nielsen, et al.
European Journal of Neurology|January 24, 2023
Risk of poststroke epilepsy after reperfusion therapies: A national cohort studyHanna Eriksson, Annika Nordanstig, Alexandros Rentzos, et al.
Food Chemistry|August 2, 2024
Minimizing anti-nutritional factors in wet protein extraction from Swedish faba beans through the application of response surface methodologyJing Lu, Galia Zamaratskaia, Maud Langton, et al.
JAMA Dermatology|January 15, 2015
BRAFV600E protein expression in primary cutaneous malignant melanomas and paired metastasesHanna Eriksson, Abdlsattar Zebary, Ismini Vassilaki, et al.
Journal for Immunotherapy of Cancer|May 28, 2020
In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanomaHaris Babačić, Janne Lehtiö, Yago Pico de Coaña, et al.
Seizure|August 29, 2021
Brain injury markers in new-onset seizures in adults: A pilot studyHanna Eriksson, Rakesh Kumar Banote, David Larsson, et al.
Behavioural and Cognitive Psychotherapy|July 9, 2021
Treating co-morbid insomnia and social anxiety disorder with sequential CBT protocols: a single-case experimental studyDaniel Wallsten, Annika Norell-Clarke, Sven Alfonsson, et al.
Journal of the American Academy of Dermatology|May 6, 2014
Risk of cutaneous malignant melanoma in patients with celiac disease: a population-based studyBenjamin Lebwohl, Hanna Eriksson, Johan Hansson, et al.
Pageof 8